Latest1 information on COVID-19

Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)

Not Recruiting

Trial ID: NCT00009646

Age - 2 Hours-6 Hours Gender - All Accepting Healthy Volunteers - No

Purpose

This trial was to determine whether giving low-dose indomethacin to infants weight 500 to 999 grams (approximately 1 to 2 pounds) at birth improves their survival without cerebral palsy or developmental problems at 18 to 22 months of age.

Official Title

Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)

Stanford Investigator(s)

David K. Stevenson, M.D.

Eligibility


Inclusion Criteria:

   - Birth weight 500 to 999 grams;

   - Postnatal age greater than 2 hours;

Exclusion Criteria:

   - Unable to administer study drug within 6 hours of birth;

   - Structural heart disease and/or renal disease;

   - Dysmorphic features or congenital abnormalities;

   - Tocolytic therapy with indomethacin or other prostaglandin inhibitor within 72 hours
   prior to delivery;

   - Overt clinical bleeding from more than one site;

   - Platelet count less than 50 x 109/L;

   - Hydrops;

   - Not considered viable

View More
View Less

Intervention(s):

drug: indomethacin

drug: Indomethacin

drug: Placebo

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

©2022 Stanford Medicine